% | $
Quotes you view appear here for quick access.

Optimer Pharmaceuticals, Inc. (OPTR) Message Board

  • mikeadd Dec 14, 2011 7:02 PM Flag

    Dificid as second-line treatment

    Just having a "smoke" and thought and wondered whether it would be a necessarily "bad' think if Dificed were to become second-line treatment but still make high profits, ie, widely prescribed (but I believe the first line will eventually proved to be in the end more expensive long term, which I'm sure it will be).

12.780.00(0.00%)Oct 23 4:00 PMEDT